LSIPR 50 2018: Jim Tananbaum

24-08-2018

Jim Tananbaum was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

jim-tananbaum.jpg

 

 


LSIPR 50 2018, Jim Tananbaum, DNAnexus, genome informatics, data management, cloud, investment, AstraZeneca, genomics research, drug discovery

LSIPR